Company: INDP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021759
Chunk: 53

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 8
Chunk 53
---
2025 and 2024, respectively. Total cash payments for the operating lease totaled
$78,176
and $75,899
during the nine months ended September 30, 2025 and 2024, respectively. The lease expired on October 31, 2025.

NOTE
9: SEGMENT INFORMATION

The
Company operates in one business segment, focusing on the development of a novel and patented systemically administered anti-cancer and
anti-viral immunotherapy. The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The
CODM assesses performance for the segment based on operating expenses as reported in the accompanying interim consolidated statements
of operations.

As
such, the CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess
the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budgeted versus
actual results is used in assessing performance of the segment.

The
following table presents reportable segment loss, including significant expenses regularly provided to the CODM, attributable to the
Company’s reportable segment for the periods presented:

 SCHEDULE OF REPORTABLE SEGMENT LOSS 

    2025  
    2024  
    2025  
    2024 

    Three months ended  
    Nine months ended 

    September 30  
    September 30 

    2025  
    2024  
    2025  
    2024 
  
    Research and development: 

    External research and development 
    $1,193,955  
    $839,008  
    $5,197,944  
    $2,543,772 
  
    Internal personnel costs 
     323,768  
     627,029  
     1,297,733  
     2,227,380 
  
    Total research and development 
     1,517,723  
     1,466,037  
     6,495,677  
     4,771,152 
  
    General and administrative 
     1,130,764  
     1,676,020  
     5,182,132  
     6,423,029 
  
    Other income, net 
     (39,088) 
     (73,021)